Chondromyxoid fibroma of the rib mimics a chondrosarcoma on 18F-FDG PET/CT

被引:6
作者
Makis, William [1 ]
Ciarallo, Anthony [2 ]
Lisbona, Robert [2 ]
机构
[1] Brandon Reg Hlth Ctr, Dept Nucl Med, Brandon, MB, Canada
[2] McGill Univ, Royal Victoria Hosp, Dept Nucl Med, Ctr Hlth, Montreal, PQ H3A 1A1, Canada
关键词
Chondromyxoid fibroma; CMF; chondrosarcoma; CT; fluorodeoxyglucose; FDG; PET/CT; FDG-PET; LESIONS; BONE; TUMORS;
D O I
10.1258/ar.2011.100526
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Chondromyxoid fibroma (CMF) is a rare benign bone tumor of chondroid origin that occurs mostly in the metaphyses of long bones. CMF can occasionally mimic a chondrosarcoma on CT, and the literature on the 18F-FDG PET/CT imaging characteristics of CMF tumors is limited. In the presented case, a large histologically proven CMF chest wall mass was initially misinterpreted as a chondrosarcoma. This case highlights a potential pitfall in the PET/CT evaluation of these rare benign bone tumors.
引用
收藏
页码:554 / 556
页数:3
相关论文
共 50 条
  • [31] Unexpected foci of 18F-FDG uptake in the breast detected by PET/CT: incidence and clinical significance
    Litmanovich, Diana
    Gourevich, Konstantin
    Israel, Ora
    Gallimidi, Zahava
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (10) : 1558 - 1564
  • [32] 18F-FDG Uptake in Neurosarcoid Dural Plaque on PET/CT
    Khodarahmi, Iman
    Turbin, Roger E.
    Frohman, Larry P.
    Ghesani, Nasrin
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (09) : E410 - E411
  • [33] Increased 18F-FDG uptake in degenerative disease of the spine:: Characterization with 18F-FDG PET/CT
    Rosen, Ron S.
    Fayad, Laura
    Wahl, Richard L.
    JOURNAL OF NUCLEAR MEDICINE, 2006, 47 (08) : 1274 - 1280
  • [34] 18F-FDG PET/CT in the evaluation of patients suspected of paraneoplastic neurological syndrome
    Garcia Vicente, A. M.
    Vega Caicedo, C. H.
    Mondejar Solis, R.
    de Ayala Fernandez, J. A.
    Garrido Robles, J. A.
    Pena Pardo, F. J.
    Munoz Pasadas, M.
    del Saz Saucedo, P.
    Jimenez Londono, G. A.
    Leon Martin, A.
    Soriano Castrejon, A.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2015, 34 (04): : 236 - 243
  • [35] Adrenal disease with 18F-FDG PET/CT: A daily challenge for nuclear physicians
    Delcroix, O.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2018, 42 (04): : 271 - 284
  • [36] Is SUVmax of 18F-FDG PET/CT Predictive Factor for Malignancy in Gastrointestinal Tract?
    Ozaslan, Ersin
    Kiziltepe, Melih
    Addulrezzak, Ummuhan
    Kula, Mustafa
    Bozkurt, Oktay
    Kut, Engin
    Duran, Ayse O.
    Ucar, Mahmut
    Sakalar, Teoman
    Dogan, Ender
    Topaloglu, Ulas S.
    Inanc, Mevlude
    Ozkan, Metin
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2021, 24 (08) : 1217 - 1224
  • [37] Observer Variation in Interpreting 18F-FDG PET/CT Findings for Lymphoma Staging
    Hofman, Michael S.
    Smeeton, Nigel C.
    Rankin, Sheila C.
    Nunan, Tom
    O'Doherty, Michael J.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (10) : 1594 - 1597
  • [38] 18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer
    Krause, Bernd J.
    Herrmann, Ken
    Wieder, Hinrich
    zum Bueschenfelde, Christian Meyer
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 : 89S - 96S
  • [39] Primary Tumor 18F-FDG Avidity Affects the Performance of 18F-FDG PET/CT for Detecting Gastric Cancer Recurrence
    Kim, Soo Jeong
    Cho, Young Seok
    Moon, Seung Hwan
    Bae, Jae Moon
    Kim, Sung
    Choe, Yearn Seong
    Kim, Byung-Tae
    Lee, Kyung-Han
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (04) : 544 - 550
  • [40] The usefulness of 18F-FDG PET/MRI fusion image in diagnosing pancreatic tumor: comparison with 18F-FDG PET/CT
    Nagamachi, Shigeki
    Nishii, Ryuichi
    Wakamatsu, Hideyuki
    Mizutani, Youichi
    Kiyohara, Shogo
    Fujita, Seigo
    Futami, Shigemi
    Sakae, Tatefumi
    Furukoji, Eiji
    Tamura, Shozo
    Arita, Hideo
    Chijiiwa, Kazuo
    Kawai, Keiichi
    ANNALS OF NUCLEAR MEDICINE, 2013, 27 (06) : 554 - 563